Ilika plc Delivers First Customer Shipments of Stereax® M300 Stacked Batteries

Ilika Plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has announced it has made a number of first customer shipments of stacked Stereax® M300 batteries from its UK manufacturing facility. Further to its announcement of 11 April 2023, these shipments are the first of a series of planned deliveries of Stereax M300 batteries to customers including CubeWorks, the developer of millimeter-scale smart sensing solutions for IoT, and Lura Health, a leading developer of wearable intraoral biosensors for salivary diagnostics. Stereax batteries can be configured such that they can be stacked, which provides customers with the flexibility to adapt the battery capacity for their application.

The small form factor of M300 batteries is of particular interest to Ilika’s customers due to their compact, high-density and high-power characteristics. CubeWorks is designing CubiSensTM, a next generation sensing platform, aiming to transform biopharma cold chain logistics, security control, asset protection and environment monitoring.

Lura Health has developed the world’s first salivary diagnostic, wearable sensor, first embedded in traditional orthodontic appliances including retainers, bands, and brackets, and eventually in prosthodontic appliances including dentures, implants, and bridges. Worn in the mouth continually throughout the day, it continually measures analytes in saliva, and provides real time streams of health data by Bluetooth Low Energy to a smartphone.

Cirtec Update

Ilika and Cirtec Medical LLC (‘Cirtec’), a strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, are continuing to finalise the terms of their intended partnership.

Graeme Purdy, Ilika Plc’s Chief Executive Officer said: “Building on the first shipments of Stereax M50 cells last month, our team has delivered the first batches of Stereax M300 batteries to support our customers’ product development programmes. CubeWorks and Lura Health are strong examples of breakthrough technology being enabled by Stereax products. We will work closely with Cirtec to jointly market Stereax technology and ramp up production capacity to support our customers’ needs going forward.”

Gyouho Kim, CubeWorks Chief Executive Officer, commented: We are thrilled to start integrating Ilika’s breakthrough battery technology to further enhance our CubiSensTM product lineup. Batteries have traditionally been one of the major bottlenecks in IoT, and Ilika’s battery technology offers a unique balance of form factor and performance that can complement our ultra-efficient SoC (System-on-Chip) solution to achieve exciting new products.”

Daniel Weinstein, Lura Health Chief Executive Officer, commented: “Small form factor is important in the design of Lura Health’s salivary diagnostics sensor. We are looking forward to qualifying Ilika’s technology and understanding its potential benefits to our future product road map.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Solid state design drives weight, cost and efficiency gains

Solid state design offers Ilika a compelling path to value through weight savings, pack simplification and improved EV performance.

Search

Search